EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer
ZY Dong, JT Zhang, SY Liu, J Su, C Zhang, Z Xie… - …, 2017 - Taylor & Francis
Patients with EGFR mutations showed unfavorable response to programmed cell death-1
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer
ZY Dong, JT Zhang, SY Liu, J Su… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Patients with EGFR mutations showed unfavorable response to programmed cell death-1
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …
[PDF][PDF] EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer
ZY Dong, JT Zhang, SY Liu, J Su, C Zhang, Z Xie… - 2017 - researchgate.net
Patients with EGFR mutations showed unfavorable response to programmed cell death-1
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …
[引用][C] EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer
ZY Dong, JT Zhang, SY Liu, J Su, C Zhang, Z Xie… - …, 2017 - cir.nii.ac.jp
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing
impaired response to PD-1 blockade in non-small cell lung cancer | CiNii Research CiNii 国立 …
impaired response to PD-1 blockade in non-small cell lung cancer | CiNii Research CiNii 国立 …
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer
ZY Dong, JT Zhang, SY Liu, J Su, C Zhang, Z Xie… - …, 2017 - elibrary.ru
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing
impaired response to PD-1 blockade in non-small cell lung cancer КОРЗИНА ПОИСК …
impaired response to PD-1 blockade in non-small cell lung cancer КОРЗИНА ПОИСК …
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer.
ZY Dong, JT Zhang, SY Liu, J Su, C Zhang, Z Xie… - …, 2017 - europepmc.org
Patients with EGFR mutations showed unfavorable response to programmed cell death-1
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …
[HTML][HTML] EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer
ZY Dong, JT Zhang, SY Liu, J Su, C Zhang, Z Xie… - …, 2017 - ncbi.nlm.nih.gov
Patients with EGFR mutations showed unfavorable response to programmed cell death-1
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer.
ZY Dong, JT Zhang, SY Liu, J Su, C Zhang, Z Xie… - …, 2017 - europepmc.org
Patients with EGFR mutations showed unfavorable response to programmed cell death-1
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …
(PD-1) blockade immunotherapy in non-small cell lung cancer (NSCLC). Yet the underlying …